Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fagus | 1 | 2014 | 1 | 0.470 |
Why?
|
| Hemiptera | 1 | 2014 | 3 | 0.460 |
Why?
|
| Plant Diseases | 1 | 2014 | 36 | 0.450 |
Why?
|
| Schistosoma mansoni | 4 | 2014 | 12 | 0.350 |
Why?
|
| Vaccines | 3 | 2014 | 30 | 0.330 |
Why?
|
| Schistosomiasis mansoni | 3 | 2014 | 7 | 0.320 |
Why?
|
| Papio | 6 | 2014 | 78 | 0.310 |
Why?
|
| Antibodies, Helminth | 4 | 2014 | 9 | 0.270 |
Why?
|
| Antigens, Helminth | 4 | 2014 | 10 | 0.270 |
Why?
|
| Entamoebiasis | 2 | 2013 | 2 | 0.180 |
Why?
|
| Monkey Diseases | 2 | 2013 | 16 | 0.180 |
Why?
|
| Fraxinus | 1 | 2020 | 1 | 0.180 |
Why?
|
| Coleoptera | 1 | 2020 | 15 | 0.170 |
Why?
|
| Immunoglobulin G | 3 | 2014 | 266 | 0.140 |
Why?
|
| Animals | 9 | 2020 | 10074 | 0.120 |
Why?
|
| Vaccines, DNA | 2 | 2014 | 11 | 0.120 |
Why?
|
| Disease Resistance | 1 | 2014 | 18 | 0.120 |
Why?
|
| Calpain | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cross Protection | 1 | 2014 | 2 | 0.110 |
Why?
|
| Schistosoma haematobium | 1 | 2014 | 2 | 0.110 |
Why?
|
| Entamoeba histolytica | 1 | 2013 | 2 | 0.110 |
Why?
|
| Schistosomiasis | 1 | 2014 | 9 | 0.110 |
Why?
|
| Immunoglobulin A | 1 | 2013 | 22 | 0.110 |
Why?
|
| Antibodies, Protozoan | 2 | 2013 | 8 | 0.100 |
Why?
|
| Endemic Diseases | 1 | 2011 | 1 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2008 | 28 | 0.080 |
Why?
|
| Streptococcus pyogenes | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cricetinae | 3 | 2014 | 129 | 0.070 |
Why?
|
| Vaccination | 3 | 2014 | 174 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2008 | 114 | 0.070 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2007 | 2 | 0.070 |
Why?
|
| Protozoan Vaccines | 1 | 2007 | 5 | 0.070 |
Why?
|
| Antinematodal Agents | 1 | 2007 | 3 | 0.070 |
Why?
|
| Trichuris | 1 | 2007 | 5 | 0.070 |
Why?
|
| Fenbendazole | 1 | 2007 | 8 | 0.070 |
Why?
|
| Papio cynocephalus | 1 | 2007 | 5 | 0.070 |
Why?
|
| Trichuriasis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Macrolides | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 133 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2008 | 512 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 474 | 0.060 |
Why?
|
| Parasite Egg Count | 2 | 2014 | 9 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1405 | 0.050 |
Why?
|
| Female | 6 | 2014 | 14627 | 0.050 |
Why?
|
| Larva | 1 | 2020 | 28 | 0.040 |
Why?
|
| Cytokines | 2 | 2014 | 439 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 80 | 0.040 |
Why?
|
| Vaccines, Subunit | 2 | 2011 | 6 | 0.040 |
Why?
|
| Epitopes | 2 | 2013 | 180 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 462 | 0.040 |
Why?
|
| Male | 4 | 2014 | 13013 | 0.040 |
Why?
|
| Biomphalaria | 1 | 2014 | 1 | 0.030 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2014 | 4 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2014 | 8 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2014 | 23 | 0.030 |
Why?
|
| Galectins | 1 | 2013 | 2 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2014 | 38 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 23 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2014 | 51 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2014 | 75 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 79 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2014 | 103 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 107 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 396 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 279 | 0.020 |
Why?
|
| Primate Diseases | 1 | 2011 | 2 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 277 | 0.020 |
Why?
|
| Serum | 1 | 2011 | 9 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 18 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 1149 | 0.020 |
Why?
|
| Pharynx | 1 | 2008 | 14 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 29 | 0.020 |
Why?
|
| Virulence | 1 | 2008 | 144 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2007 | 12 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2007 | 6 | 0.020 |
Why?
|
| Lectins | 1 | 2007 | 12 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 50 | 0.020 |
Why?
|
| Blood | 1 | 2007 | 33 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 56 | 0.020 |
Why?
|
| CHO Cells | 1 | 2007 | 96 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 50 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 253 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 440 | 0.020 |
Why?
|
| Intestines | 1 | 2007 | 117 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 506 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 4470 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 635 | 0.010 |
Why?
|
| Humans | 3 | 2011 | 27101 | 0.010 |
Why?
|